Type 2 & other diabetes

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019

Diabetes Obes MetabPublished Sequential cohort study

Authors' conclusion

By examining longitudinal trends in mortality and hospitalisations according to different characteristics in people with type 2 diabetes in England, we have identified important targets for improvement through changes in health policy and care delivery.

Study context

Population
People with T2D aged ≥20 years in England, 2009–2019, National Diabetes Audit
Exposure
2018-2019 vs 2009-2011
Outcome
Total and cause-specific mortality rates; hospitalisation rates for MI, stroke, HF, kidney and liver disease
Methodological detailsNational Diabetes Audit data, discretised Poisson regression adjusted for age, sex, ethnicity, socio-economic deprivation and diabetes duration
  • National Diabetes Audit data
  • Discretised Poisson regression adjusted for age, sex, ethnicity, socio-economic deprivation and diabetes duration

Main finding

As reported in the abstract

Total mortality · 2009-2011 to 2018-2019
2018-2019 vs 2009-2011Relative risk (95% CI)
Aged 20-74 years
0.96(0.95–0.97)
Aged ≥75 years
0.93(0.92–0.94)

Observational data: associations, not effects.

Further findings

Total mortality by ethnicity, aged 20-74 years

RR (CI)
WhiteUnchanged · over the same time period1.00 (0.99–1.01)

Total mortality by area deprivation

RR (CI)
Least deprived0.91 (0.88–0.94)
Most deprived0.97 (0.95–1.00)

Composite of CV hospitalisations and mortality by age · 2009-2011 vs 2018-2019

RR (CI)
Aged 20-49 years1.20 (1.14–1.27)
Aged 50-74 years1.04 (1.03–1.05)
Aged ≥75 yearsDeclined0.85 (0.84–0.86)

Total mortality by area deprivation

Total mortality declined more in least vs most deprived areas

Hospitalisation for kidney and liver disease

Rates increased in all age groups

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019. Diabetes Obes Metab. Published 1 September 2025. doi:10.1111/dom.70025

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.